References
- Waldenström J. Incipient myelomatosis or ‘essential hyperglobulinemia with fibrogenopenia’– A new syndrome. Acta Med Scan 1944; 117: 216
- Waldenström J. Zwei interessante Syndrome mit Hyperglobulinemia. Schweiz Med Wochenschr 1948; 78: 927
- Martin NH. Macroglobulinemia. A clinical and pathological study. Q J Med 1960; 29: 179
- Mackenzie MR, Fudenberg HH. Macroglobulinemia: an analysis of forty patients. Blood 1962; 39: 874
- Cohen RJ, Bohannon RA, Wallerstein RO. Waldenström's macroglobulinemia: Correlation between expanded plasma volume and increased serum viscosity. Blood 1970; 35: 394
- McCallister BD, Bayrd ED, Harrison EG, Jr. Primary macroglobulinemia. Review with a report on thirty-one cases and notes on the value of continuous chlorambucil therapy. Am J Med 1967; 43: 394
- Stein R, Ellman L, Block KJ. The clinical correlates of IgM M-components: an analysis of thirty-four patients. Am J Med Sci 1975; 269: 209
- Krajny M, Prozanski W. Waldenström's macroglobulinemia: review of 45 cases. CMA J 1976; 114: 899
- Case DC, Jr, Lee BJ, Clarkson BD. Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine, and BCNU: M-2 protocol. Am J Med 1977; 63: 897
- Case DC, Jr. Chemotherapy of plasma-cell myeloma. N Engl J Med 1980; 302: 407
- Case DC, Jr. Chemotherapy for myeloma. Blood 1980; 55: 1070
- Case DC, Jr., Sonneborn HL, Paul SD, et al. Combination chemotherapy for multiple myeloma with BCNU, cyclophosphamide, vincristine, melphalan, and prednisone (M-2 protocol). Oncology 1985; 42: 137
- Kempin S, Lee B, III, Thaler H, et al. Combination chemotherapy of advanced chronic lymphocytic leukemia: the M-2 protocol, vincristine, BCNU, cyclophosphamide, melphalan, and prednisone. Blood 1982; 60: 1110
- Case DC, Jr., Porensky R, Fanning J. Combination chemotherapy of Stage III and IV chronic lymphocytic leukemia with the M-2 protocol (BCNU, cyclophosphamide, vincristine, melphalan, and prednisone). Oncology 1985; 42: 350
- Case DC, Jr. Comparison of COP and M-2 Protocol as therapy for nodular lymphoma. Oncology 1984; 41: 159–163
- Case DC, Jr. Combination chemotherapy (M-2 protocol: BCNU, cyclophosphamide, vincristine, melphalan, prednisone) for Waldenström's macroglobulinemia: Preliminary report. Blood 1982; 59: 934
- Cancer 1982; 49: 2112
- Wright DJ, Jenkins DE, Jr. Simplified method for estimation of serum and plasma viscosity in multiple myeloma and related disorders. Blood 1970; 36: 516
- Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958; 53: 157
- Cox DR. The Analysis of Binary Data. Chapman and Hall, New York 1970
- Cox DR. Regression models and life tables. J R Stat Soc Ser B 1972; 34: 187
- Olubayede OA, Bademosi O, David-West A, et al. Monoclonal gammopathy (Waldenström's macroglobulinemia) producing specific red cell antibody. J Clin Pathol 1976; 29: 219
- Shulman G, Lynch SR, Bezwoda WR, et al. Serum betalipoprotein and other specific protein concentrations in patients with immunocytoma. J Clin Pathol 1976; 29: 458
- Naproli VM, Nichols CW, Wright RE. Malignant lymphoma of the nasopharynx in Waldenström's macroglobulinemia: report of a case with severe epistaxis. South Med J 1977; 70: 508
- Dalakas MC, Flaum MA, Rick M, et al. Treatment of polyneuropathy in Waldenström's macroglobulinemia: role of paraproteinemia and immunologic studies. Neurology 1983; 33: 1406
- Krausz Y, Zlatnick A. Macroglobulinemia of Waldenström associated with severe osteolytic lesions. Acta Haematol 1977; 58: 307
- Torrey JJ, Katakkar SB. Treatable meningeal involvement in Waldenström's macroglobulinemia. Ann Intern Med 1984; 101: 345
- Filuk RB, Warren PW. Broncoalveolar lavage in Waldenström's macroglobulinemia with pulmonary infiltrates. Thorax 1986; 41: 409
- Chelazzi G, Bettini R, Pinatti G. Bone marrow patterns and survival in Waldenström's macroglobulinemia. Lancert 1979; 2: 965
- Horsman DE, Card RT, Skinnider LF. Waldenström's macroglobulinemia terminating in acute leukemia: a report of three cases. Am J Hematol 1983; 15: 97
- Bruera E, Villamayor R, Roca E, et al. Response of Waldenström's macroglobulinemia to pentostatin (2'-deoxycoformycin). Cancer Treat Rep 1986; 70: 546